Optimization of insulin treatment in children

Related Experiment Video

Updated: Oct 30, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

P G Swift1

  • 1Children's Hospital, Leicester Royal Infirmary, UK.

Annals of Medicine
|February 7, 1998
PubMed

Insights

Managing childhood diabetes requires a comprehensive, child-focused approach beyond insulin. This includes diet, exercise, psychosocial support, and tailored insulin regimens for optimal metabolic control and reduced long-term complications.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Type 1 diabetes in children and adolescents is a chronic, evolving condition requiring lifelong management.
  • Optimal metabolic control is crucial but challenging, necessitating a multifaceted approach.
  • Early and continuous intervention is key to preventing long-term complications.

Purpose of the Study:

  • To outline a comprehensive, child-focused management strategy for pediatric diabetes.
  • To emphasize the integration of insulin therapy with lifestyle, psychosocial factors, and individual motivation.
  • To highlight the importance of specialized pediatric diabetes services.

Main Methods:

  • Integrated management encompassing insulin therapy, nutrition, physical activity, and psychosocial support.
  • Individualized treatment plans tailored to the child's changing needs and habits.
  • Negotiation of biochemical targets and promotion of self-care behaviors, including insulin adjustments.

Main Results:

  • A holistic approach improves metabolic control and patient engagement.
  • Tailoring insulin regimens to lifestyle factors enhances treatment adherence.
  • Specialized pediatric diabetes services are essential for successful outcomes.

Conclusions:

  • Effective pediatric diabetes management requires a comprehensive, individualized, and supportive strategy.
  • Addressing psychosocial factors and promoting self-care are critical components.
  • Well-resourced pediatric diabetes services lead to reduced long-term vascular complications.

More Related Videos

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells06:33

Optimized Protocol for Generating Functional Pancreatic Insulin-secreting Cells from Human Pluripotent Stem Cells

Published on: February 2, 2024

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...